Evidence map›Paper›PMID 41767109›Full record

ArticlePhysics and imaging in radiation oncology2026

Robustness evaluation of carbon ion radiotherapy for ventricular tachycardia.

Yuya Miyasaka, Mayumi Ichikawa, Hikaru Souda, Yuki Tominaga, Yuhi Wakisaka, Hongbo Chai, Miyu Ishizawa, Masashi Koto, Takeo Iwai

Abstract read
In one paragraph

Article in Physics and imaging in radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yuya MiyasakaDepartment of Heavy Particle Medical Science, Yamagata University Graduate School of Medical Science, Yamagata, Japan.
Mayumi IchikawaDepartment of Radiation Oncology, Yamagata University, Faculty of Medicine, Yamagata, Japan.
Hikaru SoudaDepartment of Heavy Particle Medical Science, Yamagata University Graduate School of Medical Science, Yamagata, Japan.
Yuki TominagaDepartment of Heavy Particle Medical Science, Yamagata University Graduate School of Medical Science, Yamagata, Japan.
Yuhi WakisakaDepartment of Heavy Particle Medical Science, Yamagata University Graduate School of Medical Science, Yamagata, Japan.
Hongbo ChaiDepartment of Heavy Particle Medical Science, Yamagata University Graduate School of Medical Science, Yamagata, Japan.
Miyu IshizawaDepartment of Heavy Particle Medical Science, Yamagata University Graduate School of Medical Science, Yamagata, Japan.
Masashi KotoDepartment of Radiation Oncology, Yamagata University, Faculty of Medicine, Yamagata, Japan.
Takeo IwaiDepartment of Heavy Particle Medical Science, Yamagata University Graduate School of Medical Science, Yamagata, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Favorable clinical outcomes of carbon-ion radiotherapy (CIRT) for ventricular arrhythmia have been reported, and optimal treatment strategies are being explored. We assessed the robustness of CIRT plans against cardiac motion in ventricular tachycardia. Electrocardiographic (ECG)-gated computed tomography (CT) images at end-diastole and end-systole were used for planning, and dose distributions were recalculated on the opposite phase to evaluate dosimetric changes. Cardiac motion reduced target coverage by about 13.8-19.0%, whereas a 5-mm margin or robust optimization reduced the decrease approximately to 5%. An optimization approach that accounts for cardiac motion using ECG-gated CT provided a favorable balance for clinical application.

Indexed as

Carbon-ion therapyCardiac motionRobustnessTreatment planningVentricular Tachycardia

Identifiers

PMID41767109
PMCPMC12945577

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.